Molecular Partners Ag rose 8.06% in premarket trading. The company's stock price increase may be attributed to the recent news of X-Chem expanding its strategic collaboration with Orion Pharma, which could potentially benefit Molecular Partners Ag due to the positive impact on the biotech industry.
Comments
No comments yet